News
Welcome! Here you can find novelties and news about Biofarm.
Construire Parc Fotovoltaic
Instalarea unei noi capacități de producere a energiei din surse solare de 0,5 MW putere instalată
Instalarea unei noi capacități de producere a energiei din surse solare de 0,5 MW putere instalată
Biofarm reports 9% EBITDA growth in the first nine months of 2024
Biofarm (ticker symbol BIO), one of Romania's largest drugmakers, has announced a 9% increase in EBITDA in the first nine months o...
Read moreBiofarm records a net profit of 77 million lei in 2023, up 9% compared to 2022
Biofarm, one of the most important drug manufacturers in Romania, ended 2023 with a net profit of about 77 million lei, up 9% fro...
Read moreBiofarm increases turnover by 10% in the first 9 months of 2023
Biofarm recorded a net profit of 69.9 million lei in the first nine months of the year, up 6% compared to the same period last yea...
Read moreBiofarm records a net profit of 50.1 million lei in the first half of the year, up 15% compared to the first half of 2022
Biofarm has recorded a 17% increase in turnover for the first half of 2023 compared to the same period last year. Net profit for t...
Read moreBiofarm records a net profit of 70.9 million lei in 2022, up by 18% compared to 2021
Biofarm reports positive developments for the preliminary (unaudited) results of 2022, recording a turnover of 277 million lei, up...
Read moreBiofarm aims for a 17% increase in turnover in 2023
Biofarm estimates a turnover of approximately 325 million lei for this year, which represents a 17% increase compared to last yea...
Read moreBiofarm records a net profit of 65.7 million lei in the first nine months of the year, up 20%
Biofarm recorded a turnover of 208.9 million lei, up 17%, and a net profit of 65.7 million lei, up 20%, compared to the same perio...
Read moreBiofarm records a net profit of 43.6 million RON in the first six months of the year, up 20%
Biofarm reports significant increases in the first half of the year compared to the same period of 2021: turnover is increasing by...
Read moreBiofarm aims to reach a 16% increase in turnover for 2022
Biofarm estimates a 16% increase in turnover this year, after recording a value of 239 million RON and an EBITDA of approximately ...
Read moreBiofarm registers a net profit of 60 million lei in 2021, up by 11% compared to 2020
Biofarm reports positive evolution for the preliminary results of 2021: turnover of 239 million lei and a net profit of 60 million...
Read moreBiofarm registers a 54.8million RON net profit in the first nine months of the year, with an increase of 20% compared to the same period of 2020
Biofarm reports significant increases for the first nine months of the year compared to the same period of 2020. Biofarm registere...
Read moreBiofarm celebrates 100 years of uninterrupted activity and inaugurates one of the most modern drug factories in Romania following an investment of over 35 million euros
Biofarm inaugurated a new production and testing facility in Bucharest, in which over 35 million euros were invested.
Read moreFour years of continuous growth for Biofarm. In the centennial year, the company continues to invest and expand in foreign markets
Biofarm registered between 2017 and 2020, an aggregate increase of 8% in turnover and 15% in profit, thus managing to strengthen i...
Read moreBiofarm concludes the first semester of 2021 with a net profit of 36.4 million RON
Biofarm ended the first half of this year with a net profit of 36.4 million RON. The number symbolises an increase of approximate...
Read moreBiofarm ends the first quarter of 2021 with a net profit of 22.5 million lei and significant increases in the Consumer Healthcare segment
Biofarm ended the first quarter of this year with a net profit of 22.5 million lei, increasing by over 21% compared to the same p...
Read moreBiofarm will make investments of 47.4 million lei in 2021
Biofarm will make investments of over 47 million lei in 2021. These aim to equip the new production unit, but also the modernizati...
Read moreBiofarm Marks The Centenary With Its Anniversary Campaign "100 years investing in the future"
Biofarm celebrates its centenary this year and marks the event through an anniversary campaign with the message "100 years investi...
Read moreBiofarm targets a 15% turnover increase in 2021
The Romanian drug manufacturer targets a 15% turnover increase in 2021. The company plans to obtain a value of sales revenues of o...
Read moreBIOFARM turnover grows 8% in 2020 compared to 2019
The result is due to the sustained efforts of the company to maintain investments at a competitive level throughout 2020, but also...
Read moreBiofarm responds to the challenges brought by the wave of diseases with COVID 19 according to the principles and values assumed by the company
Biofarm employees remain on the front line to be able to provide Romanian patients with the treatments they need.
Read moreCătălin Vicol (Biofarm): „România are șansa acum să renască din punct de vedere economic și poate s-o facă dacă își ascultă cu atenție oamenii”
Forbes România a invitat comunitatea de business din România să răspundă la cele mai importante chestiuni ale momentului în ...
Read moreCătălin Vicol, Biofarm: Ne dorim să intensificăm activitatea de export, în perioada viitoare
Producătorul de medicamente Biofarm (BIO) țintește să intensifice exporturile, care în prezent reprezintă 2% din cifra de af...
Read moreBiofarm donează 1 milion de lei pentru lupta împotriva Covid-19
București, 15.04.2020 – Biofarm se alătură luptei de combatere a noului Coronavirus în România printr-o donație de 1 milio...
Read moreCEO Biofarm: Provocările acestui an sunt potenţiala majorare a preţurilor la materii prime şi insuficienţa forţei de muncă calificată
Producătorul român de medicamente Biofarm (simbol bursier BIO) şi-a planificat pentru acest an creşterea cotei de piaţă şi ...
Read more